ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Race and TargImmune to develop new cancer therapies
pharmaceutical-technology
July 12, 2017Australian-based specialist pharmaceutical firm Race Oncology has executed a Letter of Intent (LoI) with Swiss-based biotechnology TargImmune Therapeutics to enter a joint venture (JV) between the two companies to develop new and improved cancer therapies
Pharma Sources Insight July 2025
